Novartis AG Statistics

Total Valuation

Novartis AG has a market cap or net worth of CAD 330.12 billion. The enterprise value is 365.52 billion.

Market Cap	330.12B
Enterprise Value	365.52B

Important Dates

The next estimated earnings date is Tuesday, October 28, 2025.

Earnings Date	Oct 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-3.37%
Shares Change (QoQ)	-0.96%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.84B

Valuation Ratios

The trailing PE ratio is 17.73 and the forward PE ratio is 14.47.

PE Ratio	17.73
Forward PE	14.47
PS Ratio	4.39
PB Ratio	5.76
P/TBV Ratio	n/a
P/FCF Ratio	12.53
P/OCF Ratio	11.64
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.26, with an EV/FCF ratio of 13.87.

EV / Earnings	19.63
EV / Sales	4.86
EV / EBITDA	11.26
EV / EBIT	13.99
EV / FCF	13.87

Financial Position

The company has a current ratio of 0.82, with a Debt / Equity ratio of 0.78.

Current Ratio	0.82
Quick Ratio	0.50
Debt / Equity	0.78
Debt / EBITDA	1.37
Debt / FCF	1.69
Interest Coverage	17.47

Financial Efficiency

Return on equity (ROE) is 32.49% and return on invested capital (ROIC) is 16.47%.

Return on Equity (ROE)	32.49%
Return on Assets (ROA)	11.88%
Return on Invested Capital (ROIC)	16.47%
Return on Capital Employed (ROCE)	26.39%
Revenue Per Employee	991,869
Profits Per Employee	245,406
Employee Count	75,883
Asset Turnover	0.55
Inventory Turnover	2.17

Taxes

In the past 12 months, Novartis AG has paid 2.69 billion in taxes.

Income Tax	2.69B
Effective Tax Rate	12.62%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	22.44
200-Day Moving Average	n/a
Relative Strength Index (RSI)	59.46
Average Volume (20 Days)	6,838

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novartis AG had revenue of CAD 75.27 billion and earned 18.62 billion in profits. Earnings per share was 9.34.

Revenue	75.27B
Gross Profit	57.41B
Operating Income	26.16B
Pretax Income	21.29B
Net Income	18.62B
EBITDA	32.12B
EBIT	26.16B
Earnings Per Share (EPS)	9.34

Full Income Statement

Balance Sheet

The company has 9.18 billion in cash and 44.51 billion in debt, giving a net cash position of -35.33 billion.

Cash & Cash Equivalents	9.18B
Total Debt	44.51B
Net Cash	-35.33B
Net Cash Per Share	n/a
Equity (Book Value)	57.36B
Book Value Per Share	29.58
Working Capital	-7.88B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 28.35 billion and capital expenditures -2.00 billion, giving a free cash flow of 26.36 billion.

Operating Cash Flow	28.35B
Capital Expenditures	-2.00B
Free Cash Flow	26.36B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 76.28%, with operating and profit margins of 34.76% and 24.74%.

Gross Margin	76.28%
Operating Margin	34.76%
Pretax Margin	28.28%
Profit Margin	24.74%
EBITDA Margin	42.68%
EBIT Margin	34.76%
FCF Margin	35.02%

Dividends & Yields

Novartis AG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	57.26%
Buyback Yield	3.37%
Shareholder Yield	n/a
Earnings Yield	5.64%
FCF Yield	7.98%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Novartis AG has an Altman Z-Score of 3.73 and a Piotroski F-Score of 6.

Altman Z-Score	3.73
Piotroski F-Score	6